Cohen Cheryl
Insider CIK 1529371 · MDVN Chief Commercial Officer · MEIP Director · VTL Director · IBRX Director · TKAI Director · ARPO Director · CLDX Director · CYTR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2026-10-02 | 2026-10-06 | 55,979 | — | $0 | 55,979 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2026-10-02 | 2026-10-06 | 81,056 | $10.50 | $851.1K | 100,309 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2026-10-02 | 2026-10-06 | 55,979 | $2.98 | $166.8K | 181,365 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2026-07-02 | 2026-07-06 | 55,979 | — | $0 | 111,958 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2026-07-02 | 2026-07-06 | 55,979 | $2.98 | $166.8K | 256,596 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2026-07-02 | 2026-07-06 | 131,210 | $9.50 | $1.25M | 125,386 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2026-06-25 | 2026-06-29 | 26,000 | — | $0 | 26,000 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2026-06-09 | 2026-06-10 | 65,600 | — | $0 | 65,600 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 162,786 | — | $0 | 162,786 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 16,500 | — | $0 | 16,500 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-17 | 16,500 | — | $0 | 16,500 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2024-06-11 | 2024-06-13 | 77,633 | — | $0 | 77,633 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 11,300 | — | $0 | 11,300 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 158,263 | — | $0 | 158,263 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2022-07-05 | 2022-07-07 | 87,500 | — | $0 | 87,500 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2022-06-16 | 2022-06-17 | 27,200 | — | $0 | 27,200 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2022-06-14 | 2022-06-15 | 167,937 | — | $0 | 167,937 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2021-08-23 | 2021-08-24 | 14,801 | $10.12 | $149.8K | 200,617 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2021-08-20 | 2021-08-24 | 9,976 | $10.00 | $99.8K | 215,418 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2021-08-18 | 2021-08-19 | 2,133 | $10.03 | $21.4K | 225,394 | SEC↗ |
| IBRX ImmunityBio, Inc. | S Sale | 2021-08-17 | 2021-08-19 | 43,398 | $10.12 | $439.2K | 227,527 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2021-07-01 | 2021-07-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award | 2021-06-30 | 2021-07-02 | 8,140 | $1.52 | $12.4K | 16,160 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2021-06-17 | 2021-06-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| IBRX ImmunityBio, Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 26,064 | — | $0 | 26,064 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award | 2021-03-31 | 2021-04-02 | 8,020 | $1.54 | $12.4K | 8,020 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2021-02-01 | 2021-02-03 | 17,857 | — | $0 | 17,857 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-08-11 | 2020-08-13 | 30,000 | $9.96 | $298.8K | 270,925 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2020-07-02 | 2020-07-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2020-06-24 | 2020-06-26 | 52,144 | — | $0 | 52,144 | SEC↗ |
| NK NantKwest, Inc. | A Award deriv | 2020-06-10 | 2020-06-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2020-04-10 | 2020-04-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2019-07-11 | 2019-07-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2019-06-18 | 2019-06-19 | 21,400 | — | $0 | 21,400 | SEC↗ |
| NK NantKwest, Inc. | A Award | 2019-06-06 | 2019-06-07 | 300,925 | — | $0 | 300,925 | SEC↗ |
| VTL VITAL THERAPIES INC | S Sale | 2018-09-12 | 2018-09-14 | 3,500 | $0.55 | $1.9K | 0 | SEC↗ |
| ARPO Aerpio Pharmaceuticals, In | A Award deriv | 2018-06-20 | 2018-06-22 | 42,800 | — | $0 | 42,800 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2018-06-13 | 2018-06-14 | 9,100 | — | $0 | 9,100 | SEC↗ |
| VTL VITAL THERAPIES INC | A Award deriv | 2018-05-23 | 2018-05-25 | 29,538 | — | $0 | 29,538 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2017-06-30 | 2017-07-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| VTL VITAL THERAPIES INC | A Award deriv | 2017-05-23 | 2017-05-25 | 45,022 | — | $0 | 45,022 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | A Award deriv | 2016-06-16 | 2016-06-16 | 12,000 | — | $0 | 12,000 | SEC↗ |
| VTL VITAL THERAPIES INC | A Award deriv | 2016-05-24 | 2016-05-26 | 21,599 | — | $0 | 21,599 | SEC↗ |
| CYTR CYTRX CORP | A Award deriv | 2015-12-15 | 2015-12-17 | 180,000 | — | $0 | 180,000 | SEC↗ |
| VTL VITAL THERAPIES INC | P Buy | 2015-10-26 | 2015-10-27 | 3,500 | $7.17 | $25.1K | 3,500 | SEC↗ |
| VTL VITAL THERAPIES INC | A Award deriv | 2015-07-14 | 2015-07-15 | 12,581 | — | $0 | 12,581 | SEC↗ |
| TKAI Tokai Pharmaceuticals Inc | A Award deriv | 2015-04-09 | 2015-04-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2014-02-18 | 2014-02-20 | 39,000 | — | $0 | 39,000 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2014-02-04 | 2014-02-06 | 7,000 | — | $0 | 32,436 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2013-10-24 | 2013-10-28 | 25,000 | — | $0 | 325,000 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2013-10-24 | 2013-10-28 | 25,000 | $9.61 | $240.3K | 50,439 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2013-10-24 | 2013-10-28 | 23,000 | $65.40 | $1.50M | 27,439 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2013-10-24 | 2013-10-28 | 2,000 | $66.02 | $132.0K | 25,439 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2013-10-23 | 2013-10-28 | 25,000 | — | $0 | 350,000 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2013-10-23 | 2013-10-28 | 25,000 | $63.05 | $1.58M | 25,439 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2013-10-23 | 2013-10-28 | 25,000 | $9.61 | $240.3K | 50,439 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2013-08-02 | 2013-08-06 | 25,000 | — | $0 | 350,000 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2013-08-02 | 2013-08-06 | 25,000 | $9.61 | $240.3K | 50,439 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2013-08-02 | 2013-08-06 | 25,000 | $59.31 | $1.48M | 25,439 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2013-07-03 | 2013-07-08 | 25,000 | — | $0 | 375,000 | SEC↗ |
| MDVN MEDIVATION, INC. | M Exercise | 2013-07-03 | 2013-07-08 | 25,000 | $9.61 | $240.3K | 50,439 | SEC↗ |
| MDVN MEDIVATION, INC. | S Sale | 2013-07-03 | 2013-07-08 | 25,000 | $54.01 | $1.35M | 25,439 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2012-12-17 | 2012-12-18 | 45,000 | — | $0 | 45,000 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2012-12-07 | 2012-12-11 | 9,000 | — | $0 | 25,439 | SEC↗ |
| MDVN MEDIVATION, INC. | F Tax w/h | 2012-09-28 | 2012-10-02 | 4,361 | $56.35 | $245.7K | 6,039 | SEC↗ |
| MDVN MEDIVATION, INC. | F Tax w/h | 2012-09-28 | 2012-10-03 | 4,361 | $56.35 | $245.7K | 16,439 | SEC↗ |